Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 17;5(6):602-609.
doi: 10.1002/bco2.353. eCollection 2024 Jun.

Bibliometric analysis of focal therapy in prostate cancer research

Mohammed Shahait  1 , Sarah Ibrahim  2 , Laith Baqain  3 , Zahi Abdul-Sater  4
Affiliations

Bibliometric analysis of focal therapy in prostate cancer research

Mohammed Shahait et al. BJUI Compass. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.

Abstract

Introduction: The use of focal therapies for prostate cancer (PCa) has soared, as it controls disease and is associated with minimal side effects. Bibliometric analysis examines the global research landscape on any topic to identify gaps in the research and areas for improvement and prioritize future research efforts. This study aims to examine the research outputs and trends and collaboration landscape in the field of focal therapy for PCa on a global scale.

Methods: We searched Medline, PubMed and Scopus for peer-reviewed publications on our research topic using controlled keywords. Search results were limited to the period between 1980 and 2022, screened for duplicates and then included in our study based on prespecified eligibility criteria. The Bibliometrix Package was used for comprehensive science mapping analysis of co-authorship, co-citation and co-occurrence analysis of countries, institutions, authors, references and keywords in this field.

Results: This analysis included 2578 research articles. The annual scientific production increased from one article in 1982 to 143 in 2022 (13.21%). The average citation per year was incrementally increasing, and these documents were cited around 32.52 times. The documents included in this analysis were published in 633 sources. The international collaboration index was 22.7. In total, 6280 author keywords were identified. The most used keywords were 'prostate cancer', 'focal therapy', 'prostate' and 'photodynamic therapy'.

Conclusion: This bibliometric analysis has provided a comprehensive review of focal therapy in PCa research, highlighting both the significant growth in the field and the existing gaps that require further exploration. The study points to the need for more diverse international collaboration and exploration of various treatment modalities within the context of focal therapy.

Keywords: bibliometric; focal therapy; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.

Figures

FIGURE 1
FIGURE 1
Annual scientific production and article citation per year on focal therapies for prostate cancer research from 1980 to 2022
FIGURE 2
FIGURE 2
Journals with 35 or more publications on focal therapies for prostate cancer research from 1980 to 2022
FIGURE 3
FIGURE 3
Top 10 corresponding authors' countries on focal therapies for prostate cancer research from 1980 to 2022. The dark blue bars demonstrate the publication rate by authors from the same country (Single Country Publication; SCP). The grey bars represent the number of publications by the corresponding author's country, with at least one foreign co‐author existing (multiple countries publication, MCP)
FIGURE 4
FIGURE 4
Country collaboration on focal therapies for prostate cancer research from 1980 to 2022. The font size and circle diameter indicate the number of publications in the country within the dataset. The lines' thickness demonstrates the strength of the collaboration between the countries.
FIGURE 5
FIGURE 5
Word cloud for top author keywords focal therapies for prostate cancer research from 1980 to 2022
FIGURE 6
FIGURE 6
Co‐occurrence by authors' keywords on focal therapies for prostate cancer research from 1980 to 2022. The circle diameter represents the occurrence of the keyword. The edge size is proportional to item co‐occurrence. Co‐occurring keywords are grouped under different colours.
See this image and copyright information in PMC

References

    1. Ma C, Su H, Li H. Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol. 2021;10:627891. 10.3389/fonc.2020.627891 - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. 10.3322/caac.21442 - DOI - PubMed
    1. Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol. 2018;199(3):683–690. 10.1016/j.juro.2017.11.095 - DOI - PubMed
    1. Thompson IM. Overdiagnosis and overtreatment of prostate cancer, (in eng). Am Soc Clin Oncol Educ Book. 2012;e35–e39. 10.14694/EdBook_AM.2012.32.98 - DOI - PubMed
    1. Kinsella N, Helleman J, Bruinsma S, Carlsson S, Cahill D, Brown C, et al. Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol. 2018;7(1):83–97. 10.21037/tau.2017.12.24 - DOI - PMC - PubMed

LinkOut - more resources